Bell Investment Advisors, Inc - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bell Investment Advisors, Inc ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$914
-39.1%
38
-19.1%
0.00%
Q2 2023$1,501
+4.2%
470.0%0.00%
Q1 2023$1,440
+18.8%
47
+51.6%
0.00%
Q4 2022$1,212
+21.2%
310.0%0.00%
Q3 2022$1,000
-75.0%
31
-69.3%
0.00%
-100.0%
Q2 2022$4,000
+300.0%
101
+1342.9%
0.00%
Q4 2021$1,0007
+40.0%
0.00%
Q3 2021$050.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders